Research Collaboration Platform

The world's most granular
real-world FND dataset

NeuroLog Technologies operates a digital phenotyping and longitudinal symptom-tracking platform for Functional Neurological Disorder — the only research-grade, patient-generated dataset of its kind, spanning 16 countries and growing daily.

Explore collaboration ↓
1,952
Registered users
16 countries
27,6k
Longitudinal records
Daily, flare & adaptive logs
409
Conditions mapped
Across 5+ body systems
r=.89
Emotion–severity correlation
10,000+ daily logs
Dataset Architecture

Seven longitudinal data streams,
one integrated platform

A 29-table PostgreSQL architecture captures symptom trajectories, emotional phenotypes, co-occurring conditions, medication burden, and patient-reported outcomes — fully anonymised and structured for research use.

LOG
Daily Symptom Logs
7,455 records
Daily patient-reported severity, physical and emotional intensity, mood, sleep quality, symptom type, triggers and coping strategies.
severity emotion triggers sleep vitals
FLR
Flare Event Logs
1,000 records
Detailed flare capture with pre/post mood, symptom composition, trigger identification, coping tool effectiveness and recovery ratings.
pre/post mood technique efficacy duration
ADP
Adaptive Question Logs
13,169 records
Platform-generated adaptive symptom assessments tied to real-time severity and emotional intensity — the richest longitudinal signal in the dataset.
per-question response severity phenotype
CMB
Comorbidity Questionnaire
753 respondents · 409 conditions
Structured co-occurring condition data with diagnosis status, timing relative to FND onset, body-system category, and impact severity rating.
pre/post FND impact body system
MED
Medication Records
2,124 records
Current and historical medication burden including drug name, type, dosage, frequency and active status across the patient population.
drug type dosage frequency active
USR
User Phenotype Profiles
1,952 anonymised users
Anonymised patient profiles with FND phenotype classification, symptom domain scores, platform engagement, and subscription tier.
phenotype FMD/FS/cognitive engagement
Most prevalent co-occurring conditions — n=753 respondents
46.9%
Generalised Anxiety Disorder
42.5%
PTSD / Complex PTSD
38.0%
Migraine incl. vestibular
35.5%
Fibromyalgia / Chronic Widespread Pain
40.3%
Neurodivergence prevalence
Collaboration Framework

Four pathways to partnership

NeuroLog operates under a formal data governance framework. All partnerships are governed by Data Use and Collaboration Agreements with clear attribution rights, co-investigator status, and ethical oversight.

01 — ACADEMIC

Research Collaboration

Joint research projects with universities, academic medical centres, and independent researchers. NeuroLog brings the dataset, analytical infrastructure, and patient community access; partners bring academic resources, publication channels, and methodological expertise.

  • Co-investigator status and full attribution
  • Anonymised dataset access under formal DUA
  • Co-authorship on resulting publications
  • Experience sampling and longitudinal study design support
Formal DUA required
02 — CLINICAL

Clinical Partnership

Collaboration with NHS trusts, specialist FND clinics, rehabilitation services, and MDTs. Platform tools can support longitudinal patient monitoring, outcome tracking between appointments, and service evaluation.

  • Platform access for clinical cohort monitoring
  • Customised reporting for MDT use
  • Patient-facing data portrait tools
  • Joint service evaluation and audit support
NHS-compatible data standards
03 — COMMERCIAL

Data Licensing

Structured data access for pharmaceutical companies, medtech firms, and health technology developers requiring real-world evidence from a rare, under-served neurological population. Particularly suited to organisations working in depression, chronic pain, or functional symptoms.

  • Aggregated or structured anonymised datasets
  • Custom analysis and phenotype-specific extracts
  • Patient-reported outcome validation support
  • Longitudinal real-world evidence for regulatory dossiers
Commercial licensing terms
04 — EDUCATION

Training & Education

NeuroLog's ESRM (Emotional Symptom Regulation Model) Certificate and Diploma programmes — accredited by ReAttach Academy — provide evidence-based CPD for clinicians working with FND. Institutional group licensing and bespoke MDT training packages available.

  • Accredited CPD — Certificate (10hrs) and Diploma (40hrs)
  • Group and institutional licensing
  • Bespoke MDT workshop design
  • Data-grounded curriculum built on 10,000+ patient logs
Accredited CPD
GOVERNANCE
Formal agreements, always
Every data collaboration is governed by a Data Use and Collaboration Agreement. No raw data sharing without formal ethical and legal framework in place.
ATTRIBUTION
Co-investigator status
NeuroLog Technologies and Steve Painter are credited as co-investigators on all research outputs. Attribution and intellectual property rights are established at agreement stage.
COMMUNITY
Patient-first research
Our 1,700+ users are the foundation of this platform. Research partnerships must align with the community's interests and contribute meaningfully to FND understanding and care.
Published Research

Evidence-grounded from the outset

NeuroLog research has achieved top 10% readership on ResearchGate and been presented at international FND conferences.

Academic partners University of Oxford K J Somaiya College of Physiotherapy ReAttach Academy
2026 — PUBLISHED
Emotional Drivers of Functional Movement Disorder: A Real-World Analysis of Patient-Reported Symptom Data
ReAttach Affect Coach Journal, 2(1): 131–140
Painter S, Zeestraten-Bartholomeus P, Akulwar-Tajane I, Pattison J, Adeyemi A
2025 — PREPRINT
Co-occurring Conditions in Functional Neurological Disorder: Prevalence, Clustering, and Allostatic Context from 631 Community Respondents
ResearchGate Preprint — targeting JNNP / Journal of Psychosomatic Research
Painter S et al. — manuscript in preparation
2025 — TOP 10% READERSHIP
Beyond Distress and Resilience: Identification of Seven Distinct Emotional Phenotypes in FND Through Large-Scale Digital Phenotyping
ResearchGate — peer-reviewed
Painter S — NeuroLog Technologies
Upcoming — June 2026
6th International FND Society Conference — Baltimore
Three accepted poster presentations
FND SOCIETY 2026
Get in touch

Let's explore what's
possible together

Whether you're a researcher, clinician, industry partner, or funder — if you're working on FND or related functional and neurological conditions, we'd welcome a conversation.

Please reach out with a brief description of your organisation and the type of collaboration you have in mind.

Email
steven@neurolog.app
Web
www.neuro-log.com
Platform
NeuroLog Technologies Ltd · Co. No. 16525711
Founder
Steve Painter — Patient-researcher, digital phenotyping
Areas open for collaboration
Academic research partnerships
→
NHS & clinical service integration
→
Pharma & medtech data licensing
→
Digital health investment
→
CPD & clinical education partnerships
→
Rare disease patient advocacy
→
Data governance
All data partnerships operate under formal Data Use and Collaboration Agreements with defined attribution rights, ethical oversight, and co-investigator status for NeuroLog Technologies.